Shares of Curis, Inc. (NASDAQ:CRIS – Get Rating) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.71 and traded as high as $0.88. Curis shares last traded at $0.81, with a volume of 151,384 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on Curis in a report on Thursday, May 18th. They issued a “hold” rating on the stock.
Curis Stock Performance
The stock has a market capitalization of $78.26 million, a PE ratio of -1.47 and a beta of 2.93. The business has a 50 day moving average of $0.75 and a two-hundred day moving average of $0.71.
Institutional Investors Weigh In On Curis
A number of institutional investors have recently modified their holdings of CRIS. HRT Financial LP acquired a new stake in shares of Curis in the fourth quarter valued at $29,000. Engineers Gate Manager LP purchased a new position in Curis in the first quarter valued at $32,000. UBS Group AG boosted its holdings in Curis by 183.6% in the third quarter. UBS Group AG now owns 51,332 shares of the biotechnology company’s stock valued at $36,000 after purchasing an additional 33,231 shares during the period. Virtu Financial LLC purchased a new position in Curis in the fourth quarter valued at $51,000. Finally, Bank of Montreal Can purchased a new position in Curis in the second quarter valued at $59,000. 38.72% of the stock is owned by institutional investors and hedge funds.
Curis Company Profile
Curis, Inc engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints.
- Get a free copy of the StockNews.com research report on Curis (CRIS)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Curis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curis and related companies with MarketBeat.com's FREE daily email newsletter.